NCT07119151

Brief Summary

This is a post-market prospective observational study to prospectively collect clinical data to confirm the long-term safety and clinical performance of implants and abutments Helix Short in a daily dental practice setting, by means of success and survival rates of these devices. Additionally, from the collected data, the study aims to identify previously unknown side-effects and monitor the known side-effects and contraindications stated on the IFU, identify and analyze emerging risks on the basis of factual evidence, and ensure the continued acceptability of the benefit-risk ratio with the intent to verify that the intended purpose is correct for all JJGC products involved in the procedure that get in contact with the patient.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started Sep 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Sep 2025Dec 2028

First Submitted

Initial submission to the registry

July 29, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 12, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

3.3 years

First QC Date

July 29, 2025

Last Update Submit

August 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Implant success rate

    Implant success rate (including survival as one of the criteria for success) of implants at 3 years after implant loading.

    From the implant loading to the 36-months of follow-up

Secondary Outcomes (13)

  • Implant survival rate

    From the implant loading to the 36-months of follow-up

  • Prosthetic survival and success rates

    From the implant loading to 36-months of follow-up

  • Change in peri-implant bone level

    From the implant loading to 36-months of follow-up

  • Soft tissue assessment - Visible Plaque

    From the implant loading to 36-months of follow-up

  • Evaluation of the crown/implant ratio

    From the implant loading to 36-months of follow-up

  • +8 more secondary outcomes

Study Arms (1)

Treatment

Patients with maxillary and mandible atrophy in need of one or more dental implants and who were evaluated as suitable for the installation of Helix Short implants.

Device: Dental Implant

Interventions

Dental Implant placement and loading.

Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with atrophic maxilla and mandible, who need of one or more dental implants with opposing dentition (natural teeth or teeth/implant-supported fixed restorations) and who qualify for placement of Helix Short implants.

You may qualify if:

  • Patients with atrophic maxilla and mandible, who need of one or more dental implants with opposing dentition (natural teeth or teeth/implant-supported fixed restorations) and who qualify for placement of Helix Short implants.
  • Collaborative patient.
  • Patient with opposing dentition (natural teeth or fixed and/or removable restorations)

You may not qualify if:

  • Contraindication according to the IFU: This product is contraindicated for patients who show signs of allergy or hypersensitivity to the chemical components of titanium. Implants with a length of 4 mm are contraindicated for single and overdenture rehabilitations, and they are contraindicated for total and multiple restorations when not associated with implants with lengths greater than or equal to 5.5 mm.
  • Patients with periodontal disease, severe alcohol/tobacco consumption, bruxism, high use of bisphosphonates or proton pump inhibitors (PPI), radiotherapy to the neck and head in the last 3 years, uncontrolled systemic diseases.
  • Pregnant patient.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Dental Implants

Intervention Hierarchy (Ancestors)

Dental MaterialsBiomedical and Dental MaterialsDental ProsthesisProsthodonticsDentistryProstheses and ImplantsEquipment and SuppliesManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2025

First Posted

August 12, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

August 12, 2025

Record last verified: 2025-08